Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
14.6%
% of AGNG's 82 holdings also in CANC
25.0%
% of CANC's 48 holdings also in AGNG
Overlap by Weight
Sector Drift (AGNG minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in AGNG |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 3.3% | 5.4% | 3.3% |
|
AMGEN INC | 2.9% | 2.8% | 2.8% |
|
MERCK & CO. INC. | 2.9% | 2.7% | 2.7% |
|
BRISTOL-MYERS SQUIBB CO | 2.7% | 4.0% | 2.7% |
|
BEIGENE LTD. SPONSORED ADR | 1.9% | 2.7% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
AGNG Overweight Relative to CANC
 |
ALCON, INC. | 3.1% |
|
WELLTOWER, INC. | 3.1% |
|
ROCHE HOLDING AG-BR | 3.1% |
|
EDWARDS LIFESCIENCES CORP | 3.1% |
|
JOHNSON & JOHNSON | 3.0% |
|
BOSTON SCIENTIFIC CORP | 3.0% |
 |
ASTRAZENECA PLC-SPONS ADR | 3.0% |
|
STRYKER CORP | 3.0% |
 |
NOVO NORDISK A/S-B | 2.9% |
 |
MEDTRONIC PLC | 2.9% |
AGNG Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -5.7% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -5.1% |
|
BRIDGEBIO PHARMA, INC. | -4.5% |
|
NOVARTIS AG | -4.3% |
|
ASTRAZENECA PLC | -4.2% |
|
NUVALENT, INC. CLASS A | -3.9% |
|
SUMMIT THERAPEUTICS INC | -3.9% |
|
GENMAB A/S SPONSORED ADR | -3.4% |
 |
MERUS N.V. | -3.2% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -3.0% |